Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma AidsDHA:PHARMAID -2.55%73 Current Ratio is 3.20 as of Mar. 2026, which is 4% above its 10-year median of 3.07. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Pharma Aids ranks better than 60.77% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Pharma Aids's current ratio for the quarter that ended in Mar. 2026 was 3.20.
Pharma Aids has a current ratio of 3.20. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Pharma Aids's Current Ratio or its related term are showing as below:
DHA:PHARMAID'
s Current Ratio Range Over the Past 10 Years
Min: 1.78 Med: 3.07 Max: 8.03
Current: 3.2
During the past 13 years, Pharma Aids's highest Current Ratio was 8.03. The lowest was 1.78. And the median was 3.07.
DHA:PHARMAID's Current Ratio is ranked better than 60.77% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.5
vs DHA:PHARMAID: 3.20
Pharma Aids (DHA:PHARMAID) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Pharma Aids Current Ratio Related Terms
Pharma Aids Current Ratio Historical Data
* Premium members only.
The historical data trend for Pharma Aids's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:PHARMAID vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Pharma Aids's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Aids Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's Current Ratio distribution charts can be found below:
* The bar in red indicates where Pharma Aids's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Aids (DHA:PHARMAID) has a Current Ratio of 3.20 as of Mar. 2026. This is near median its historical median of 3.07. Over the past decade, Pharma Aids' Current Ratio has ranged from 1.78 to 8.03. According to the industry distribution chart, Pharma Aids ranks #335 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 39.2%.
Is Pharma Aids' Current Ratio too high?
Pharma Aids' current Current Ratio of 3.20 is near median its 10-year median of 3.07. Over the past 10 years, this metric has ranged from a low of 1.78 to a high of 8.03. The Medical Devices & Instruments industry median Current Ratio is 2.50. Pharma Aids' value of 3.20 is 28% above this industry median. Based on the distribution chart, Pharma Aids ranks #335 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pharma Aids ranks #335 out of 854 companies for Current Ratio. This puts Pharma Aids in the upper half of its industry. The industry median Current Ratio is 2.50. Pharma Aids' value of 3.20 is 28% above this benchmark. Historically, Pharma Aids' own Current Ratio has ranged from 1.78 to 8.03 over the past decade. While the company's 10-year median is 3.07 vs. the industry median of 2.50, Pharma Aids has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.50, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Aids's current Current Ratio of 3.20 is 28% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Aids's current Current Ratio is 3.20, which is near median its own 10-year median of 3.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current Current Ratio is 3.20, which is near median its 10-year median of 3.07 and 28% above the Medical Devices & Instruments industry median of 2.50. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current Current Ratio is 3.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued.
The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56.
GuruFocus considers Pharma Aids to be Modestly Undervalued.
Key valuation signals for DHA:PHARMAID:
Current Ratio: 3.20 (near median its 10-year median of 3.07)
GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
Industry Position: 28% above the Medical Devices & Instruments median (#335 of 854)
No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score
Get the complete analysis for DHA:PHARMAID
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:PHARMAID has been successfully added to your 
